首页> 外国专利> Abzyme against the chemokine receptor CCR-5, a gene encoding the same, transformants in which the gene is introduced, and the anti-HIV agent using them

Abzyme against the chemokine receptor CCR-5, a gene encoding the same, transformants in which the gene is introduced, and the anti-HIV agent using them

机译:对抗趋化因子受体CCR-5(编码该基因的基因)的抗体,导入了该基因的转化子以及使用它们的抗HIV药物

摘要

PPROBLEM TO BE SOLVED: To obtain an antibody enzyme capable of decomposing a chemokine receptor CCR-5 which is a co-receptor of AIDS virus (HIV) to eliminate its function and being utilized for preventing the infection with the AIDS virus or treating AIDS, and an anti-HIV medicine utilizing the same enzyme. PSOLUTION: A monoclonal antibody is prepared by using a peptide constituting an extracellular domain of the chemokine receptor CCR-5 as an immunizing source, and the amino acid sequences and base sequences of variable regions of an H-chain and L-chain in the monoclonal antibody are decided. Then, molecular modelings regarding the amino acid sequences are performed to estimate their three-dimensional structures and whether or not they have each a catalytic triad residual structure, is identified. The monoclonal antibodies, ECL2B-2 and ECL2B-3 having the catalytic triad residual structures are collected as the antibody enzymes. PCOPYRIGHT: (C)2005,JPO&NCIPI
机译:

要解决的问题:获得能够分解趋化因子受体CCR-5的抗体酶,该趋化因子受体是AIDS病毒(HIV)的共同受体,以消除其功能并被用于预防AIDS病毒或HIV感染。治疗艾滋病,以及使用相同酶的抗HIV药物。

解决方案:使用构成趋化因子受体CCR-5胞外域的肽作为免疫源,以及H链和L链可变区的氨基酸序列和碱基序列,制备单克隆抗体。单克隆抗体中的决定。然后,进行有关氨基酸序列的分子建模以估计其三维结构,并确定它们是否各自具有催化三联体残基结构。具有催化三联体残基结构的单克隆抗体ECL2B-2和ECL2B-3被收集作为抗体酶。

版权:(C)2005,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号